Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24499 | 259 | 30.2 | 55% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ERBA | Author keyword | 1 | 38% | 1% | 3 |
2 | COLLISION METASTASIS | Author keyword | 1 | 33% | 1% | 2 |
3 | ANTIBODIES TO THYROID PEROXIDASE | Author keyword | 1 | 50% | 0% | 1 |
4 | AUTOIMMUNE THYROID | Author keyword | 1 | 50% | 0% | 1 |
5 | GACHON UNIV MED | Address | 1 | 50% | 0% | 1 |
6 | GENE DISORDERS | Author keyword | 1 | 50% | 0% | 1 |
7 | LACTATIONAL CHANGE | Author keyword | 1 | 50% | 0% | 1 |
8 | MALIGNANT BREAST NEOPLASMS | Author keyword | 1 | 50% | 0% | 1 |
9 | NAT SCI HLTH SCI | Address | 1 | 50% | 0% | 1 |
10 | PROGRAM EVALUAT SURVEILLANCE | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MULTIPLE PRIMARY BREAST | 7 | 57% | 3% | 8 |
2 | AUTOIMMUNE THYROID DISORDERS | 1 | 30% | 1% | 3 |
3 | MOUSE MAMMARY GLANDS | 1 | 30% | 1% | 3 |
4 | 2ND PRIMARY MALIGNANCY | 1 | 23% | 1% | 3 |
5 | C ERBA BETA | 1 | 23% | 1% | 3 |
6 | COLLISION METASTASIS | 1 | 50% | 0% | 1 |
7 | ERBA BETA | 1 | 50% | 0% | 1 |
8 | MALIGNANT BREAST DISEASE | 1 | 50% | 0% | 1 |
9 | PRIMARY MALIGNANCY RISK | 1 | 50% | 0% | 1 |
10 | THYROID SUPPLEMENTS | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Primary HT and risk for breast cancer: a systematic review and meta-analysis | 2012 | 6 | 29 | 62% |
Breast cancer in association with thyroid disorders | 2003 | 38 | 9 | 78% |
Second primary malignancy risk in thyroid cancer survivors: A systematic review and meta-analysis | 2007 | 38 | 34 | 41% |
The thyroid, iodine and breast cancer | 2003 | 25 | 31 | 23% |
Role of lipid peroxidation and oxidative stress in the association between thyroid diseases and breast cancer | 2008 | 8 | 58 | 19% |
THYROID-DISEASES AND BREAST-CANCER | 1990 | 39 | 28 | 43% |
THYROID-FUNCTION AND CANCER | 1989 | 2 | 55 | 53% |
THYROID-HORMONE ACTION | 1993 | 8 | 52 | 27% |
Spontaneous remission of cancer-A thyroid hormone dependent phenomenon? | 1999 | 12 | 45 | 9% |
THYROID AND STEROID-HORMONE REGULATION OF PROTOONCOGENE EXPRESSION | 1989 | 6 | 28 | 11% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GACHON UNIV MED | 1 | 50% | 0.4% | 1 |
2 | NAT SCI HLTH SCI | 1 | 50% | 0.4% | 1 |
3 | PROGRAM EVALUAT SURVEILLANCE | 1 | 50% | 0.4% | 1 |
4 | UNIV REG S REG SKANE | 1 | 19% | 1.2% | 3 |
5 | CASILLA 16443 | 0 | 33% | 0.4% | 1 |
6 | DISCIPLINA BIOESTATIST | 0 | 33% | 0.4% | 1 |
7 | KEELUNG LINKOU CHANG GUNG MEM HOSP | 0 | 33% | 0.4% | 1 |
8 | OBSTET GYNECOL MAISTRASSE | 0 | 33% | 0.4% | 1 |
9 | THER EUTVASC | 0 | 33% | 0.4% | 1 |
10 | GANSU PROV TUMOR HOSP | 0 | 25% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000197182 | FAMILIAL NON MEDULLARY THYROID CANCER//FAMILIAL THYROID CARCINOMA//CANC MOL GENET GEMOCA |
2 | 0.0000156729 | RESISTANCE TO THYROID HORMONE//THYROID HORMONE RECEPTOR//V ERBA |
3 | 0.0000156452 | SODIUM IODIDE SYMPORTER//SODIUM IODIDE SYMPORTER NIS//IODIDE TRANSPORT |
4 | 0.0000122465 | MULTIPLE PRIMARY MALIGNANCIES//MULTIPLE PRIMARY MALIGNANT NEOPLASMS//MULTIPLE PRIMARY NEOPLASMS |
5 | 0.0000105394 | 1 METHYL 1 NITROSOUREA//MAMMARY DYSPLASIA//BREAST DIFFERENTIATION |
6 | 0.0000093624 | CHERNOBYL//PEDIATRIC THYROID CANCER//CHERNOBYL NUCLEAR ACCIDENT |
7 | 0.0000092702 | CHRONIC LYMPHOCYTIC THYROIDITIS//LYMPHOCYTIC THYROIDITIS//ADVANCED TUMOR STAGE |
8 | 0.0000076980 | RADIATION SIALADENITIS//DIFFUSE LIVER UPTAKE//POST THERAPEUTIC SCAN |
9 | 0.0000071389 | COLONY PROMOTING ACTIVITY//PHOSPHOAMINO ACIDS//KIDNEY EXTRACT |
10 | 0.0000071319 | IMMORTALIZATION OF HUMAN CELLS//IMMORTALIZED HUMAN CELLS//MOL ENVIRONM HLTH |